1. Home
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Hospital Universitari – HVH
  4. Articles científics - HVH
  5. View Item

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

To access the full text documents, please follow this link: https://hdl.handle.net/11351/12156

Author

Minga, Eva

Chamou, Dimitra

Kotaskova, Jana

Chatzikonstantinou, Thomas

Scarfo', Lydia

KARAKATSOULIS, GEORGIOS

Bosch, Francesc

IACOBONI, GLORIA

Other authors

Institut Català de la Salut

[Chatzikonstantinou T, Minga E, Karakatsoulis G, Chamou D] Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. [Scarfò L] Università Vita‐Salute San Raffaele, Milan, Italy. IRCCS Ospedale San Raffaele, Milan, Italy. [Kotaskova J] Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine‐Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. [Iacoboni G, Bosch F] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-10-30T11:50:15Z

2024-10-30T11:50:15Z

2024-09-17



Share

Abstract

Therapeutic strategies; Chronic lymphocytic leukemia

Estrategias terapéuticas; Leucemia linfocítica crónica

Estratègies terapèutiques; Leucèmia limfocítica crònica

This project was supported in part by AbbVie; AIRC under 5 per Mille 2018-ID. 21198 program (to PG and GG); PNRR-MAD-2022-12375673 (Next Generation EU, M6/C2_CALL 2022), Italian Ministry of Health, Rome, Italy, Conceptual development of research organization (FNBr 65269705) provided by the Ministry of Health of the Czech Republic, and National Institute for Cancer Research (Programme EXCELLES, ID Project No. LX22NPO5102) funded by the European Union—Next Generation EU.

Document Type

Article

Published version

Language

English

Subjects and keywords

Leucèmia limfocítica crònica - Tractament; Proteïnes quinases - Inhibidors - Ús terapèutic; CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases; Other subheadings::Other subheadings::Other subheadings::/antagonists & inhibitors; DISEASES::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid::Leukemia, B-Cell::Leukemia, Lymphocytic, Chronic, B-Cell; Other subheadings::Other subheadings::Other subheadings::/drug therapy; COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::transferasas::fosfotransferasas::fosfotransferasas (grupo alcohol aceptor)::proteína cinasas::proteína-tirosina cinasas; Otros calificadores::Otros calificadores::Otros calificadores::/antagonistas & inhibidores; ENFERMEDADES::neoplasias::neoplasias por tipo histológico::leucemia::leucemia linfoide::leucemia de células B::leucemia linfocítica crónica de células B; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

Publisher

Wiley

Related items

HemaSphere;8(9)

https://doi.org/10.1002/hem3.70004

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)

Articles científics - HVH [3440]